CVSA Covista Inc. Common Shares

125.28USD-0.16%Mkt Cap: 4.27B $P/E: 16.75

Covista Inc., together with its subsidiaries, provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. It operates in three segments: Chamberlain, Walden, and Medical and Veterinary. The …

HeadlineSourceTime
Older
1 Safe-and-Steady Stock on Our Buy List and 2 Facing Challenges

Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.

StockStory
Covista (CVSA) Could Be 20% Undervalued As Workforce Shortages Support Its Growth Story

How Covista Stock Has Been Behaving Around Recent Returns Covista (CVSA) has seen mixed share price moves recently, with the stock edging higher by 0.35% in the latest session but down about 4.7% over the past week and 9.1% over the past month. Across a slightly longer window, Covista is up roughly 1.4% over the past 3 months and has gained about 22.6% so far this year. Over the past 1 year the stock has declined 4.7%, while the reported 3 year and 5 year total returns are very large...

Simply Wall St.
Street Calls of the Week

Monday - Lumentum Holdings What’s the full story? Evercore initiates Lumentum Lumentum Holdings Inc (NASDAQ:LITE) at Outperform with an $1,100 target. The AI revolution has a supply-chain coronary: silicon processors run fast, but data can’t move between them. Connecting these compute clusters requires Indium Phosphide lasers—a scarce, capital-intensive material where demand outpaces supply by 30%. LITE holds the choke point, shifting pricing power and margin upstream to vertically integrated in

Investing.com
1 Small-Cap Stock with Promising Prospects and 2 That Underwhelm

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.

StockStory
Consumer Discretionary - Education Services Stocks Q2 Teardown: Covista (NYSE:CVSA) Vs The Rest

Looking back on consumer discretionary - education services stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Covista (NYSE:CVSA) and its peers.

StockStory
Covista SVP Sells 4,526 Shares for $615,000

Beck's sale reduces direct holdings by 14%, yet he retains a $4 million stake.

Motley Fool
Covista (CVSA) Stock Trades Up, Here Is Why

Shares of vocational education company Covista (NYSE:CVSA) jumped 13.3% in the afternoon session after second-quarter 2026 revenue and adjusted earnings both cleared Wall Street estimates. Covista paired mid-single-digit-plus revenue growth with a double-digit EPS beat and wider operating margins, then layered on full-year adjusted earnings guidance above consensus. Revenue rose 9.7% to $501.4 million, while adjusted EPS of $2.09 beat forecasts by about 10%, a combination that usually implies bo

StockStory
Covista Q4 Earnings & Revenues Top Estimates, Enrollments Up Y/Y

CVSA posts double-digit profit growth, record Walden enrollment and raises fiscal 2027 targets as strong execution continued across all three segments.

Zacks
Covista Inc (CVSA) (Q4 2026) Earnings Call Highlights: Record Enrollment and Strong Cash Flow ...

Company exceeds fiscal 2026 guidance with 9.3% revenue growth, expands margins, and returns $238 million to shareholders while positioning for continued expansion in fiscal 2027.

GuruFocus.com
Covista (CVSA) Q4 Earnings and Revenues Top Estimates

Covista (CVSA) delivered earnings and revenue surprises of +10.00% and +3.38%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Zacks
Covista’s (NYSE:CVSA) Q2 CY2026 Sales Top Estimates

Vocational education company Covista (NYSE:CVSA) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 9.7% year on year to $501.4 million. The company expects the full year’s revenue to be around $2.07 billion, close to analysts’ estimates. Its non-GAAP profit of $2.09 per share was 10.4% above analysts’ consensus estimates.

StockStory
Covista to Report Q4 Earnings: Here's What to Expect This Season

CVSA heads into Q4 earnings with rising enrollment and healthcare education demand expected to support revenue and profit growth.

Zacks
How Covista’s (CVSA) New Strategy Office and Board Additions Could Reshape Its Investment Narrative

Covista Inc. recently expanded its leadership bench, appointing Scott Liles as Chief Strategy and Performance Officer and President, Medical and Veterinary, while also creating a Performance Acceleration Office reporting to CEO Steve Beard. The company further broadened its governance and sector expertise by adding technology and fintech veteran Emily C. Chiu and veterinary and healthcare operator Leslie Storms to its Board of Directors. Next, we’ll examine how the new Performance...

Simply Wall St.
3 Value Stocks We’re Skeptical Of

Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built their fortunes by purchasing wonderful businesses at reasonable prices. But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues.

StockStory
Laureate Education (LAUR) Q2 Earnings and Revenues Surpass Estimates

Laureate Education (LAUR) delivered earnings and revenue surprises of +4.17% and +1.29%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Zacks
1 Profitable Stock to Own for Decades and 2 That Underwhelm

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies — as Jeff Bezos said, “Your margin is my opportunity”.

StockStory